Lucid Diagnostics (LUCD) Return on Capital Employed (QoQ) (2022 - 2026)
Lucid Diagnostics (LUCD) Return on Capital Employed (QoQ) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Lucid Diagnostics | 176.73 Mn | 143.33 Mn | 55,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6,207.00 |
| Mar 31, 2026 | -35,326.00 |
| Dec 31, 2025 | -2,883.00 |
| Sep 30, 2025 | 51,683.00 |
| Jun 30, 2025 | -175,203.00 |
| Mar 31, 2025 | 246,202.00 |
| Dec 31, 2024 | -115,024.00 |
| Sep 30, 2024 | -5,932.00 |
| Jun 30, 2024 | 20,373.00 |
| Mar 31, 2024 | 507,646.00 |
| Dec 31, 2023 | -486,021.00 |
| Sep 30, 2023 | -39,165.00 |
| Jun 30, 2023 | 4,564.00 |
| Mar 31, 2023 | -12,638.00 |
| Dec 31, 2022 | -4,505.00 |
| Sep 30, 2022 | -6,578.00 |
| Jun 30, 2022 | -1,974.00 |
| Mar 31, 2022 | 2,434.00 |